{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T19:56:41Z","timestamp":1784318201762,"version":"3.55.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"1-3","license":[{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Salem Veterans Affairs Medical Center"},{"name":"Salem Research Institute"}],"content-domain":{"domain":["clinicalkey.jp","schres-journal.com","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Schizophrenia Research"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1016\/j.schres.2016.04.051","type":"journal-article","created":{"date-parts":[[2016,6,15]],"date-time":"2016-06-15T08:46:58Z","timestamp":1465980418000},"page":"132-136","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["Adiposity-independent hypoadiponectinemia as a potential marker of insulin resistance and inflammation in schizophrenia patients treated with second generation antipsychotics"],"prefix":"10.1016","volume":"174","author":[{"given":"Mamta","family":"Sapra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donna","family":"Lawson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Iranmanesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anjali","family":"Varma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1\u20133","key":"10.1016\/j.schres.2016.04.051_bb0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.schres.2009.03.014","article-title":"Association of adiponectin and metabolic syndrome among patients taking atypical antipsychotics for schizophrenia: a cohort study","volume":"111","author":"Bai","year":"2009","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2016.04.051_bb0010","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.psyneuen.2015.03.012","article-title":"Plasma adiponectin levels in schizophrenia and role of second-generation antipsychotics: a meta-analysis","volume":"56","author":"Bartoli","year":"2015","journal-title":"Psychoneuroendocrinology"},{"issue":"1","key":"10.1016\/j.schres.2016.04.051_bb0015","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/j.1365-2265.2004.02063.x","article-title":"Serum adiponectin concentrations predict the developments of type 2 diabetes and the metabolic syndrome in elderly Koreans","volume":"61","author":"Choi","year":"2004","journal-title":"Clin. Endocrinol."},{"issue":"6","key":"10.1016\/j.schres.2016.04.051_bb0020","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1177\/070674370605100608","article-title":"Insulin resistance and adiponectin levels in drug-free patients with schizophrenia: a preliminary report","volume":"51","author":"Cohn","year":"2006","journal-title":"Can. J. Psychiatr."},{"issue":"4","key":"10.1016\/j.schres.2016.04.051_bb0025","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1038\/mp.2015.87","article-title":"C-reactive protein is increased in schizophrenia but is not altered by antipsychotics: meta-analysis and implications","volume":"21","author":"Fernandes","year":"2016","journal-title":"Mol. Psychiatry"},{"issue":"6","key":"10.1016\/j.schres.2016.04.051_bb0030","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1097\/JCP.0b013e31829e8333","article-title":"Acute effects of single-dose olanzapine on metabolic, endocrine, and inflammatory markers in healthy controls","volume":"33","author":"Hahn","year":"2013","journal-title":"J. Clin. Psychopharmacol."},{"issue":"2\u20133","key":"10.1016\/j.schres.2016.04.051_bb0035","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.schres.2008.09.008","article-title":"A cross-sectional evaluation of adiponectin plasma levels in patients with schizophrenia and schizoaffective disorder","volume":"106","author":"Hanssens","year":"2008","journal-title":"Schizophr. Res."},{"issue":"8","key":"10.1016\/j.schres.2016.04.051_bb0040","doi-asserted-by":"crossref","first-page":"3165","DOI":"10.1210\/jc.2008-0425","article-title":"Associations of adiponectin, resistin, and tumor necrosis factor-alpha with insulin resistance","volume":"93","author":"Hivert","year":"2008","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"6","key":"10.1016\/j.schres.2016.04.051_bb0045","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.1210\/jc.2011-3317","article-title":"Distinct metabolic surrogates predict basal and rebound GH secretion after glucose ingestion in men","volume":"97","author":"Iranmanesh","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1\u20132","key":"10.1016\/j.schres.2016.04.051_bb0050","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.schres.2015.08.019","article-title":"Associations of high sensitivity C-reactive protein levels in schizophrenia and comparison groups","volume":"168","author":"Joseph","year":"2015","journal-title":"Schizophr. Res."},{"issue":"12","key":"10.1016\/j.schres.2016.04.051_bb0055","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.2337\/diacare.21.12.2191","article-title":"Correct homeostasis model assessment (HOMA) evaluation uses the computer program","volume":"21","author":"Levy","year":"1998","journal-title":"Diabetes Care"},{"issue":"58","key":"10.1016\/j.schres.2016.04.051_bb0060","first-page":"47","article-title":"Differential effects of olanzapine and clozapine on plasma levels of adipocytokines and total ghrelin. Prog Neuropsychopharmacol","volume":"3","author":"Lu","year":"2015","journal-title":"Biol. Psychiatry"},{"issue":"5","key":"10.1016\/j.schres.2016.04.051_bb0065","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.diabet.2008.03.003","article-title":"Insulin sensitivity, adjusted beta-cell function and adiponectinaemia among lean drug-naive schizophrenic patients treated with atypical antipsychotic drugs: a nine-month prospective study","volume":"34","author":"Oriot","year":"2008","journal-title":"Diabete Metab."},{"issue":"11","key":"10.1016\/j.schres.2016.04.051_bb0070","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1111\/j.1463-1326.2012.01626.x","article-title":"Adiponectin increases insulin content and cell proliferation in MIN6 cells via PPAR\u03b3-dependent and PPAR\u03b3-independent mechanisms","volume":"14","author":"Rao","year":"2012","journal-title":"Diabetes Obes. Metab."},{"issue":"3","key":"10.1016\/j.schres.2016.04.051_bb0075","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1097\/01.jcp.0000218404.64619.52","article-title":"Olanzapine treatment is associated with reduced high molecular weight adiponectin in serum: a potential mechanism for olanzapine-induced insulin resistance in patients with schizophrenia","volume":"26","author":"Richards","year":"2006","journal-title":"J. Clin. Psychopharmacol."},{"issue":"2","key":"10.1016\/j.schres.2016.04.051_bb0080","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1186\/cc10021","article-title":"Clinical review: adiponectin biology and its role in inflammation and critical illness","volume":"15","author":"Robinson","year":"2011","journal-title":"Crit. Care"},{"issue":"2\u20133","key":"10.1016\/j.schres.2016.04.051_bb0085","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.schres.2010.07.012","article-title":"Head-to-head comparisons of metabolic side effects of second generation antipsychotics in the treatment of schizophrenia: a systematic review and meta-analysis","volume":"123","author":"Rummel-Kluge","year":"2010","journal-title":"Schizophr. Res."},{"issue":"7","key":"10.1016\/j.schres.2016.04.051_bb0090","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1038\/sj.npp.1301541","article-title":"Effects of olanzapine and ziprasidone on glucose tolerance in healthy volunteers","volume":"33","author":"Sacher","year":"2008","journal-title":"Neuropsychopharmacology"},{"issue":"4","key":"10.1016\/j.schres.2016.04.051_bb0095","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1016\/j.bbrc.2014.07.005","article-title":"Atypical antipsychotics induce both proinflammatory and adipogenic gene expression in human adipocytes in vitro","volume":"450","author":"S\u00e1rv\u00e1ri","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"45","key":"10.1016\/j.schres.2016.04.051_bb0100","doi-asserted-by":"crossref","first-page":"26746","DOI":"10.1074\/jbc.270.45.26746","article-title":"A novel serum protein similar to C1q, produced exclusively in adipocytes","volume":"270","author":"Scherer","year":"1995","journal-title":"Biol. Chem."},{"issue":"4","key":"10.1016\/j.schres.2016.04.051_bb0105","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/acps.12396","article-title":"Difference in inflammatory cytokine production by mononuclear cells from obese and non-obese schizophrenic patients","volume":"132","author":"Sirota","year":"2015","journal-title":"Acta Psychiatr. Scand."},{"issue":"1","key":"10.1016\/j.schres.2016.04.051_bb0110","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.schres.2013.07.044","article-title":"Elevated levels of adiponectin and other cytokines in drug na\u00efve, first episode schizophrenia patients with normal weight","volume":"150","author":"Song","year":"2013","journal-title":"Schizophr. Res."},{"issue":"12","key":"10.1016\/j.schres.2016.04.051_bb0115","doi-asserted-by":"crossref","first-page":"5875","DOI":"10.1210\/jc.2002-021884","article-title":"Evaluation of insulin sensitivity in healthy volunteers treated with olanzapine, risperidone, or placebo: a prospective, randomized study using the two-step hyperinsulinemic, euglycemic clamp","volume":"88","author":"Sowell","year":"2003","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"3","key":"10.1016\/j.schres.2016.04.051_bb0120","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1097\/JCP.0b013e3182524393","article-title":"Dysregulation of adipocytokines related to second-generation antipsychotics in normal fasting glucose patients with schizophrenia","volume":"32","author":"Sugai","year":"2012","journal-title":"J. Clin. Psychopharmacol."},{"issue":"3","key":"10.1016\/j.schres.2016.04.051_bb0125","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1210\/jc.2007-0397","article-title":"Reduced high-molecular-weight adiponectin and elevated high-sensitivity C-reactive protein are synergistic risk factors for metabolic syndrome in a large-scale middle-aged to elderly population: the Shimanami Health Promoting Program study","volume":"93","author":"Tabara","year":"2008","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2","key":"10.1016\/j.schres.2016.04.051_bb0130","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/j.1365-2796.2004.01426.x","article-title":"Adiponectin\u2013journey from an adipocyte secretory protein to biomarker of the metabolic syndrome","volume":"257","author":"Trujillo","year":"2005","journal-title":"J. Intern. Med."},{"issue":"2","key":"10.1016\/j.schres.2016.04.051_bb0135","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1210\/jc.2007-1167","article-title":"Hepatic insulin resistance in antipsychotic naive schizophrenic patients: stable isotope studies of glucose metabolism","volume":"93","author":"van Nimwegen","year":"2008","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.schres.2016.04.051_bb0140","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1210\/jc.2008-1815","article-title":"Effects of olanzapine and haloperidol on the metabolic status of healthy men","volume":"95","author":"Vidarsdottir","year":"2010","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"9","key":"10.1016\/j.schres.2016.04.051_bb0145","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.4088\/JCP.08m04654yel","article-title":"Orally disintegrating and oral standard olanzapine tablets similarly elevate the homeostasis model assessment of insulin resistance index and plasma triglyceride levels in 12 healthy men: a randomized crossover study","volume":"71","author":"Vidarsdottir","year":"2010","journal-title":"J. Clin. Psychiatry"},{"issue":"1","key":"10.1016\/j.schres.2016.04.051_bb0150","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.euroneuro.2011.03.010","article-title":"Differential effects of olanzapine and risperidone on plasma adiponectin levels over time: results from a 3-month prospective open-label study","volume":"22","author":"Wampers","year":"2012","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"4","key":"10.1016\/j.schres.2016.04.051_bb0155","doi-asserted-by":"crossref","first-page":"103","DOI":"10.5498\/wjp.v4.i4.103","article-title":"Peptides from adipose tissue in mental disorders","volume":"4","author":"W\u0119drychowicz","year":"2014","journal-title":"World J. Psychiatry"},{"issue":"5","key":"10.1016\/j.schres.2016.04.051_bb0160","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1210\/jcem.86.5.7463","article-title":"Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia","volume":"86","author":"Weyer","year":"2001","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"6","key":"10.1016\/j.schres.2016.04.051_bb0165","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.2337\/diabetes.52.6.1355","article-title":"Involvement of AMP-activated protein kinase in glucose uptake stimulated by the globular domain of adiponectin in primary rat adipocytes","volume":"52","author":"Wu","year":"2003","journal-title":"Diabetes"},{"issue":"3","key":"10.1016\/j.schres.2016.04.051_bb0170","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.molmet.2013.04.001","article-title":"Adiponectin, driver or passenger on the road to insulin sensitivity?","volume":"2","author":"Ye","year":"2013","journal-title":"Mol. Metab."}],"container-title":["Schizophrenia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996416302213?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996416302213?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,11]],"date-time":"2018-09-11T02:52:43Z","timestamp":1536634363000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920996416302213"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7]]},"references-count":34,"journal-issue":{"issue":"1-3","published-print":{"date-parts":[[2016,7]]}},"alternative-id":["S0920996416302213"],"URL":"https:\/\/doi.org\/10.1016\/j.schres.2016.04.051","relation":{},"ISSN":["0920-9964"],"issn-type":[{"value":"0920-9964","type":"print"}],"subject":[],"published":{"date-parts":[[2016,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adiposity-independent hypoadiponectinemia as a potential marker of insulin resistance and inflammation in schizophrenia patients treated with second generation antipsychotics","name":"articletitle","label":"Article Title"},{"value":"Schizophrenia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.schres.2016.04.051","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}